Abstract
We report a case of tuberculous infection of exceptional location: clivus with involvement of surrounding tissues and refractory headache without pulmonary clinic. Tuberculous osteomyelitis of the clivus is a rare entity described in areas with highest tuberculosis prevalence. This case debuts with unspecific neurological symptoms and was diagnosed by the results of microbiological study of coexisting pulmonary nodules, without associated pulmonary clinic.
References
INDIRA DEVI B, TYAGI AK, BHAT DI, SAN-TOSH V. Tuberculous osteitis of clivus. Neurol India. 2003;51: 9-70.
SELVAPANDIAN S, CHANDY MJ. Tuberculous Granuloma of clivus. Br J Neurosurg. 1993;7:581-2.
MANCUSI G, MARCS B, CZERNY C, THAL-AMER F, THURHER D, RIEDL M, ET AL. Tubercular osteomyelitis of teh clivus and the nasopharynx. HNO. 2005;53:1081-4.
AMEH EA, AGADA FO, ABUBAKAR A, AIKH-IONBARE HA, NMADU PT. Tuberculous osteitis of the cranium: a case report. West Afr J Med. 1999;18:220-2.
WALLACE RJ, BROWN-ELLIOT BA, WARD SC, CRIST CJ, MAN LB, WILSON RW. Activities of Linezolid against rapidly growing Mycobacteria. Antimicrob Agents Chemoter. 2001;45:764-7.
RODRÍGUEZ JC, RUIZ M, LÓPEZ M, ROYO M. In vitro activity of moxifloxacin, levofloxacin, gati-floxacin and linezolid against Mycobacterium tuberculosis. Int JAntimicrob Agents. 2002;20:464-7.
GINSBERG AM. Drugs in Development for Tuberculosis. Drugs. 2010;70:2201-14.
SASSE J, TEICHMANN D. Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs. Eur Respir Rev. 2009;18:291-4.
GARCÍA-VÁZQUEZ E, GÓMEZ J. Tratamiento de las infecciones relacionadas con procedimientos neu-roquirúrgicos. RevEspQuimioterap. 2007;20:36-43.
MYRIANTHEFS P, MARKANTONIS, S., VLA-CHOS, K. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother. 2006;50:3971-6.
NTZIORA F, FALAGAS ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacoter. 2007;41:296-308.
ALFFENAAR JW, VAN DER LAAN T, SIMONS S, VAN DER WERF TS, VAN DE KASTEELE PJ, DE NEELING H, VAN SOOLINGEN D. Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid. Antimicrob Agents Chemother. 2011;55:1287-9.
RUPPRECHT TA, PFISTER HW. Clinical experience with linezolid for the treatment of central nervous system infections. EurJNeurol. 2005;12:536-42.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.